Kara Leonard, MD

Basic Biostatistics Concepts for Radiation Oncologists

This lecture serves as a continuation of the basic biostatistics lecture. Dr. Leonard’s discussion of survival analysis is supplemented with real-life examples.

Disclosures:

  • Royalties from Elsevier for Biostatistics for Oncologists
  • ACRO chart review compensation.
0:00Introduction
2:25Sensitivity and Specificity, Positive/Negative Predictive Value
21:10Positive and Negative Likelihood Ratios 
28:00Receiver/Operator Curves
29:33Pre- and Post-Test Probability 
39:35Survival Analysis
41:50Kaplan-Meier Curves
1:00:19Log-Rank Test 
1:05:14Wilcoxon Rank Sum  
1:05:32Cox Proportional Hazard Model 
Kara Leonard, MD

Survival Analysis Worksheet (link to Word doc):

https://mailuc-my.sharepoint.com/:w:/g/personal/ramoska_ucmail_uc_edu/EVJhlxKkT5BCn3SvEAIL9TQBkHLMOBu8IAPQSCLAA3M7zQ?e=WMAnZL

Survival Analysis (link to Excel file):

https://mailuc-my.sharepoint.com/:x:/g/personal/ramoska_ucmail_uc_edu/EWc4cvuHvClLtufvrbRNxTkBdqqlIfJI0lCmOAzlnn4EHw?e=PHFA1t

Clifton Fuller, MD, PhD

Basic Biostatistics for Radiation Oncology Trainees

In this lecture, Dr. Fuller discusses probability distributions and significance testing, among other core biostatistics concepts. 

Dr. Fuller's supplementary data set available for download is available at:   https://doi.org/10.6084/m9.figshare.13365191.v1
0:00Introduction
5:10Types of Measurement Scales 
6:24Summarizing and Displaying Data 
9:29Probability Distributions
14:07Measures of Central Tendency, Measures of Spread 
19:00Graphical Representation 
27:44Sampling Variability, Standard Error
29:00Confidence Intervals
29:53Sample Size and Variability of Mean
30:45Significance Testing
48:45Statistical Error
51:00t-Tests 
53:45Means of More than Two Samples
55:50Multiple Comparisons and p-values 
56:30Mann-Whitney Test
58:05Kruskal-Wallis H-Test

Clifton Fuller, MD, PhD

David Sher, MD

Non-Experimental Studies and Observational Data

Dr. Sher reviews methods of critically evaluating observational data, including limitations.

0:00Introduction
6:12Bias
8:15Confounding
11:18Effect Modification
12:09Fundamental Comparisons 
14:38Univariable Calculations
15:54Fisher Exact Test
20:01Chi-squared Test
26:32Pearson Correlation
28:30Spearman Correlations 
30:33Linear Regression 
34:58Odds Ratio, Risk Ratio
36:39Logistic Regression 
40:58Building a Model 
45:59Propensity Score Analysis
47:59Instrumental Analysis
50:50Case-Control Studies 
53:10Cross-Sectional Study
55:11Cohort Study

David Sher, MD

Søren Bentzen, PhD, DMSc

Radiobiologic Principles in Radiation Oncology

Clinical Research Design

Dr. Bentzen discusses clinical trial design and what makes radiation oncology trials special.

 
0:00Introduction
2:21Discussion of historic RO trial (Copenhagen Breast Cancer Trial) 
4:06Summary of UK post-op RT trials for early breast cancer
6:08Classical hypothesis testing 
12:04Phases of clinical trials
17:19Cochrane ladder of evidence 
19:19What’s special about RO trials?
19:19Double Blinding
19:19Phase I/II or Feasibility Trials 
19:19Drug-Radiation Combinations
29:28Toxicity monitoring
32:29Dose-response relationship and trial design 
43:44Choice of endpoints

Søren Bentzen, PhD, DMSc

Peter Thall, PhD

Bayesian Statistics in Clinical Trials

 In this seminar, Dr. Thall provides an introduction to Bayesian statistics.

0:00 Introduction
2:20Elements of Bayesian Statistics
4:35Beta Distributions
5:40Simple Example
10:17Estimating Probabilities of Rare Events
11:19Simple Example, continued
14:38Example: Kaplan Meier Estimates of PFS Time Distribution for Each Dose from a Phase I-II Trial of Targeted Agent in Advanced Renal Cancer
18:15Quantifying Strength of Evidence
28:28p-values
31:50Looking at Efficacy and Toxicity- A Simple Example
34:49Utility Based Clinical Trial Design
37:47Example: A Radiation Dose-Finding Trial in Pediatric Brain Tumors
42:42Example: Randomized Subgroup-Specific Comparison of NuPrehab vs Standard of Care Effects on Post-op Morbidity after Esophageal Resection
47:47Example: PK-Guided vs. Fixed IV Busulfan Dose in Allogeneic Stem Cell Transplantation
52:26Example: Randomized Pilot Study of T-reg Cell Therapy for ARDS in Intubated COVID-19 Patients

John Kang, MD, PhD

Machine Learning for Radiation Oncologists

0:00Introduction
1:48Machine learning and statistics
3:35Modeling Nature
8:20Examples of real-life models
12:41Current state of AI in Rad Onc
14:51Deep learning for diagnosis and treatment guidance
17:07Definitions
20:11Importance of using the correct model
24:37Clinical models 
26:38Tips for creating a machine learning nomogram
27:57 Random Forest Model
33:15Improving on Kattan-type models
36:07Case study
47:22ROC curves

Additional Resources:

Coursera 1: AI for Medicine: Goes through statistical models and machine learning models. Participants should have some coding experience.

Coursera 2: Machine Learning: Understandable for beginners.

 John Kang, MD, PhD

Benjamin Movsas, MD

Analyzing and Interpreting Patient Reported Outcomes

May 26, 2021 from 8:00-9:00 a.m.

0:00Introduction
2:13Definition of PRO
4:08“Overcoming the Cons”
6:23Secondary Analysis of RTOG 0617
21:30 RTOG 9801 QOL analysis
22:43“Disadvantage of Men Living Alone Participating in RTOG Head and Neck Trials”
24:10Quality of Life
28:25 PROs and PCI (RTOG 0214)
29:55Suggested References
32:38Lung SBRT and PROs
34:22QOL Instruments
36:50PRO-CTCAE
38:22Collecting QOL data
41:15 Future of PROs/QOL
45:30PROceeding with PROs